-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Cd9Vw7m9dTFJEoH1Szch5pVKHAvLKszPc7hDUXHQlO5j//mUB8/P1XbJaCBA1IkH pJ44rH1g2RjDYg0SR4UbWA== 0000912057-96-014506.txt : 19960715 0000912057-96-014506.hdr.sgml : 19960715 ACCESSION NUMBER: 0000912057-96-014506 CONFORMED SUBMISSION TYPE: 10-C PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19960702 FILED AS OF DATE: 19960712 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: CORVAS INTERNATIONAL INC CENTRAL INDEX KEY: 0000882100 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330238812 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-C SEC ACT: 1934 Act SEC FILE NUMBER: 000-19732 FILM NUMBER: 96594204 BUSINESS ADDRESS: STREET 1: 3030 SCIENCE PARK RD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6194559800 MAIL ADDRESS: STREET 2: 3030 SCIENCE PARK ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 10-C 1 FORM 10C UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-C REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ INTERDEALER QUOTATION SYSTEM FILED PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 13a-17 OR 15d-17 THEREUNDER CORVAS INTERNATIONAL, INC. ----------------------------------- (Exact name of issuer as specified in charter) 3030 Science Park Drive, San Diego, CA 92121 -------------------------------------------------- (Address of principal executive offices) Issuer's telephone number, including area code: (619) 455-9800 ----------------------------- I. CHANGE IN NUMBER OF SHARES OF OUTSTANDING Indicate any change (increase or decrease) of 5% or more in the number of shares outstanding: 1. Title of Security: Common Stock ($0.001 par value) ----------------------------------------------------- 2. Number of shares outstanding before the change: 12,699,791 -------------------------- 3. Number of shares outstanding after the change: 13,699,791 --------------------------- 4. Effective date of change: July 2, 1996 ------------------------------------------------ 5. Method of change: Specify method (such as merger, acquisition, exchange, distribution, stock split, reverse split, acquisition of stock for treasury, etc.): Sale of -------- Common Stock ($0.001 par value) for cash. ---------------------------------------- Give brief description of transaction: Sale of 1,000,000 registered shares ----------------------------------- of Common Stock by the Company on a best efforts basis to selected --------------------------------------------------------------------------- institutional investors. --------------------------------------------------------------------------- Date: July 12, 1996 /s/ JOHN E. CRAWFORD ------------------------------ John E. Crawford Executive Vice President and Chief Financial Officer -----END PRIVACY-ENHANCED MESSAGE-----